NVS has put up a good Q4 performance on the back of momentum in its key drugs and should maintain it in 2025. Investors ...
Der Schweizer Pharmakonzern Novartis setzt seinen Expansionskurs mit einer bedeutenden Übernahme fort. Das Unternehmen gab bekannt, das US-Biopharmaunternehmen Anthos Therapeutics für eine initiale Za ...
Kesimpta was approved in August 2020 as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Vor den morgigen US-Inflationsdaten notiert der QIX Dividenden Europa Index am Dienstag kaum verändert bei 15.110 Punkten.
Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...
The raised forecast reflects increases in the sales projections for a sweep of its current drugs – including Cosentyx, Kisqali, Kesimpta, Pluvicto, and Leqvio – and more than 15 data readouts ...
“Most research and therapeutic strategies have so far focused on blocking the overactive immune system, but how cells in the brain itself,… Kesimpta (ofatumumab) is more effective than Aubagio ...